Truvian Sciences Raises $27m As It Tries To Succeed Where Theranos Failed

The idea of a benchtop blood testing system only needing a few drops of blood has gotten a bad rap since Theranos’ collapse. But that hasn’t stopped Truvian Sciences from trying to develop its own system

Leave a Reply

Your email address will not be published. Required fields are marked *